Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$71,114,424
-$9,688,974 QoQ
Shares Held
1,475,403
+27.0% QoQ
Ownership
0.692%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#11
of 196 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 23.844536035239187.ToString("F0")%
Shared 0.ToString("F0")%
None 76.15546396476081.ToString("F0")%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Mar 31, 2025CallValue
$2,596,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. GPCR ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $488,832,498 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
7,959,538 | $312,013,889 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
3,530,702 | $141,545,843 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
3,637,887 | $108,590,926 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $104,824,037 | |
| 6 | ARGX |
Argenx SE
|
136,900 | $99,971,225 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
15,219,994 | $80,513,768 | |
| 8 | GPCR |
Structure Therapeutics Inc.
This page
|
1,475,403 | $71,114,424 |
All Filings in GPCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $71,114,424 | 1,475,403 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $80,803,398 | 1,161,803 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $31,900,400 | 1,139,300 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,873,482 | 1,199,300 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,286,604 | 652,028 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $2,596,500 | 150,000 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $4,068,000 | 150,000 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $17,682,999 | 652,028 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,840,812 | 383,705 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,908,750 | 125,000 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||